Janus Henderson’s Biotech team recognized by With Intelligence’s HFM “Sector Specialist” Award
- The award signifies the team's excellent track record, extensive investing experience, and deep fundamental research, demonstrating strong risk-adjusted results for the firm’s clients.
- None.
The With Intelligence HFM US Performance Awards recognize and reward the highest achieving hedge funds, CTAs, and funds of hedge funds in the US. The Janus Henderson biotech team won in the Sector Specialist category over other sector-specific teams.
“Biotech is entering a golden age of innovation with advanced technologies enabling a rapid pace of medical breakthroughs. We continue to see exceptional potential in the sector and believe the combination of attractive valuations and new growth initiatives create compelling investment opportunities,” said Andy Acker, Portfolio Manager at Janus Henderson.
“Janus Henderson is honored to receive this award, which is a testament to the strength of our biotech team’s excellent track record, extensive investing experience and ability to add value through active management and stock selection. We are grateful for the continued support of our investors and thank With Intelligence for this recognition,” added Ali Dibadj, Chief Executive Officer at Janus Henderson.
Janus Henderson’s biotech team utilizes deep fundamental research to identify companies trading at significant disparities from intrinsic value. The specialized experience of its investment team, depth of research, and disciplined approach are demonstrated by its track record of providing strong risk-adjusted results for the firm’s clients.
The award signifies much-deserved recognition of Janus Henderson’s efforts to deliver the firm’s market-leading biotech capabilities to qualified clients.
About Janus Henderson
About Janus Henderson Janus Henderson Group is a leading global active asset manager dedicated to helping clients define and achieve superior financial outcomes through differentiated insights, disciplined investments, and world-class service. As of September 30, 2023, Janus Henderson had approximately
About the Award
The Awards are open to all US hedge fund, fund of funds, and CTA firms. US Performance Awards 2023 are awarded annually and to be eligible for an award, funds entering any of the categories must apply and meet certain requirements. Funds entering must submit a 3-year track record of monthly performance data through June 2023. There were 6 funds shortlisted in the Sector specialist category. Judges focus on absolute performance as well as standard deviation of returns and outperformance of the relevant HFM benchmark. They also take into consideration the relative AUM, nature of the investment strategy, track-records, other supporting materials and professional knowledge they have about shortlisted funds to come to their decisions.
This press release is solely for the use of members of the media and should not be relied upon by personal investors, financial advisers or institutional investors. We may record telephone calls for our mutual protection, to improve customer service and for regulatory record keeping purposes. All opinions and estimates in this information are subject to change without notice.
Janus Henderson is a trademark of Janus Henderson Group plc or one of its subsidiaries. © Janus Henderson Group plc.
View source version on businesswire.com: https://www.businesswire.com/news/home/20231113834493/en/
Candice Sun
+1 303-336-5452
candice.sun@janushenderson.com
Source: Janus Henderson Investors
FAQ
What award did Janus Henderson's Biotech team win?
What does the award recognize?
How does Janus Henderson's biotech team identify investment opportunities?
What does the award signify?
